Jennifer R. Rider, ScD, MPH
Assistant Professor
Boston University School of Public Health
Dept of Epidemiology

ScD, Harvard School of Public Health
MPH, University of Massachusetts Amherst

Pronouns: she/her/hers



My primary research interests are in prostate cancer epidemiology and the identification of patient and tumor characteristics that could reduce overdiagnosis and overtreatment. Collaborating with research pathologists, urologists, medical oncologists, molecular biologists, immunologists, virologists, and bioinformaticists, I have utilized data from a large Swedish population-based studies (CaPS and PCBaSe) and a Swedish randomized trial (SPCG-4), Swedish clinical cohorts, the Physicians’ Health Study, and the Health Professionals Follow-up Study. I am also involved in ongoing studies of HPV infection in penile carcinoma and am pursuing projects that investigate malignancies in HIV-infected populations.

2016 European Urology: Top 5 Most Downloaded Papers of 2016
2013 Harvard Medical School: The Eleanor and Miles Shore 50th Anniversary Fellowship Program for Scholars in Medicine
2013 European Urology: Best Clinical Research Paper of 2013
2012-2015 Prostate Cancer Foundation: Michael and Lori Milken-PCF Young Investigator Award
2012 American Urological Association, AUA Annual Meeting: Best Poster in Session
2012 Prostate Cancer Foundation, American Urological Association Annual Meeting: First Place Abstract
2011-2013 Harvard School of Public Health: Teaching Commendation
2009-2015 National Cancer Institute: NIH Loan Repayment Program Recipient
2008-2009 American Association of Cancer Research: Scholar-in-Training Award
2007 Harvard College: Certificate of Distinction in Teaching
2006 American Association of Cancer Research: Scholar-in-Training Award
2005 American Urological Association: Travel Award


Racial Differences in Splice Variants in Men with Localized Prostate Cancer
03/01/2018 - 02/28/2019 (PI)
Massachusetts General Hospital




Patterns in long-term prescription opioid use in patients with cancer who are HIV-infected and HIV-uninfected
02/01/2019 - 01/31/2020 (PI)
BU/BMC

ACS Institutional Research Grant Pilot Award
02/01/2019 - 01/31/2020 (PI)
BU/BMC

Novel Method for Surrogate Endpoint Evaluation in Prostate Cancer Trials
10/05/2018 - 10/31/2019 (Co-PI)
PI: Jennifer R. Rider, ScD, MPH
BU SPH

Novel Method for Surrogate Endpoint Evaluation in Prostate Cancer Trials
10/05/2018 - 10/31/2019 (Co-PI)
PI: Jennifer R. Rider, ScD, MPH
Boston University School of Public Health

Gene expression profiles in prostate tumors according to HIV status
05/01/2016 - 04/30/2017 (PI)
Boston University School of Public Health

Gene expression profiles in prostate tumors according to HIV status
05/01/2016 - 04/30/2017 (PI)
BU SPH

The Immunomodulatory and Androgen-Associated Actions of Vitamin D in Prostate Cancer
05/20/2013 - 05/20/2016 (PI)
Prostate Cancer Foundation

The Immunomodulatory and Androgen-Associated Actions of Vitamin D in Prostate Cancer
05/20/2013 - 05/20/2016 (PI)
Prostate Cancer Foundation

Chronic Stress and Racial Disparities in Prostate Cancer
09/01/2013 - 08/31/2015 (PI)
Dana Farber/Harvard Cancer Center

Inflammation and Tissue Microenvironment as Predictors of Prostate Cancer Risk, Mortality and Therapy Response among Men with an Initially Benign TURP
08/01/2012 - 07/31/2014 (PI)
Dana Farber/Harvard Cancer Cente

Showing 10 of 11 results. Show All Results

Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Trinquart L, Bill-Axelson A, Rider JR. Restricted Mean Survival Times to Improve Communication of Evidence from Cancer Randomized Trials and Observational Studies. Eur Urol. 2019 Apr 25.View Related Profiles. PMID: 31031048.
     
  2. Ahearn TU, Peisch S, Pettersson A, Ebot EM, Zhou CK, Graff RE, Sinnott JA, Fazli L, Judson GL, Bismar TA, Rider JR, Gerke T, Chan JM, Fiorentino M, Flavin R, Sesso HD, Finn S, Giovannucci EL, Gleave M, Loda M, Li Z, Pollak M, Mucci LA. Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease. Carcinogenesis. 2018 12 31; 39(12):1431-1437. PMID: 30165429.
     
  3. Vicier C, Werner L, Chipman J, Harshman LC, Patil DH, Fichorova RN, Rider JR, Sanda MG, Mucci LA, Sweeney CJ. Elevated Serum Cytokines and Trichomonas vaginalis Serology at Diagnosis Are Not Associated With Higher Gleason Grade or Lethal Prostate Cancer. Clin Genitourin Cancer. 2019 Feb; 17(1):32-37. PMID: 30348512.
     
  4. Johnson-Obaseki S, Caulley L, Corsten M, Liu G, Dimitroulakos J, Goldstein D, Irish J, Rider J. C-reactive Protein in HPV-Positive and HPV-Negative Oropharyngeal Cancer. Otolaryngol Head Neck Surg. 2019 Mar; 160(3):494-501. PMID: 30226795.
     
  5. Davidsson S, Carlsson J, Giunchi F, Harlow A, Kirrander P, Rider J, Fiorentino M, Andrén O. PD-L1 Expression in Men with Penile Cancer and its Association with Clinical Outcomes. Eur Urol Oncol. 2019 Mar; 2(2):214-221. PMID: 31017099.
     
  6. DuPre NC, Flavin R, Sfanos KS, Unger RH, To S, Gazeeva E, Fiorentino M, De Marzo AM, Rider JR, Mucci LA. Corpora amylacea in prostatectomy tissue and associations with molecular, histological, and lifestyle factors. Prostate. 2018 11; 78(15):1172-1180. PMID: 30009541.
     
  7. Stopsack KH, Ebot EM, Downer MK, Gerke TA, Rider JR, Kantoff PW, Mucci LA. Regular aspirin use and gene expression profiles in prostate cancer patients. Cancer Causes Control. 2018 Aug; 29(8):775-784. PMID: 29915914.
     
  8. Sinnott JA, Brumberg K, Wilson KM, Ebot EM, Giovannucci EL, Mucci LA, Rider JR. Differential Gene Expression in Prostate Tissue According to Ejaculation Frequency. Eur Urol. 2018 11; 74(5):545-548. PMID: 29784192.
     
  9. Erlandsson A, Carlsson J, Andersson SO, Vyas C, Wikström P, Andrén O, Davidsson S, Rider JR. High inducible nitric oxide synthase in prostate tumor epithelium is associated with lethal prostate cancer. Scand J Urol. 2018 Apr; 52(2):129-133. PMID: 29307261; DOI: 10.1080/21681805.2017.1421261;.
     
  10. Börnigen D, Ren B, Pickard R, Li J, Ozer E, Hartmann EM, Xiao W, Tickle T, Rider J, Gevers D, Franzosa EA, Davey ME, Gillison ML, Huttenhower C. Alterations in oral bacterial communities are associated with risk factors for oral and oropharyngeal cancer. Sci Rep. 2017 12 15; 7(1):17686. PMID: 29247187.
     
Showing 10 of 92 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 92 publications over 15 distinct years, with a maximum of 17 publications in 2016

YearPublications
20052
20061
20071
20084
20096
20104
20117
20128
20136
20147
201511
201617
20179
20188
20191
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

biomarkers
cancer etiology
epidemiology
infection-associated cancers
prostate cancer
gene expression
prognostic tools
disparities

I am interested in mentoring graduate students and clinicians with an interest in cancer disparities, cancer prevention, or prognostic/predictive biomarkers.

Available to Mentor as: (Review Mentor Role Definitions):
  • Project Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')

715 Albany St Talbot Building
Boston MA 02118
Google Map


Rider's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department